Merrimack will have the last patient in the door for the MM-093 trial by the end of this quarter. (Supposedly due to "many R/A trials in the clinic.") **Important - Information will be gathered by June. We'll know the results by July. Lots of interest in R/A with Merrimack last week at JP Morgan's 26th Annual Healthcare Conference in San Francisco.